Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.

Literature DB >> 965210

Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.

K D Nolph, L Miller, F C Husted, P Hirszel.

Abstract

Reduced peritoneal clearances of creatinine and urate were demonstrated repeatedly in a patient with scleroderma and a patient with diabetes mellitus. Urea clearances were not significantly different from usual values. The findings suggest decreased peritoneal membrane permeability and/or area (if urea clearance is flow limited). Clearances increased to usual values with intraperitioneal isoproterenol in the patient with diabetes. There was no effect of isoproterenol in the patient with scleroderma.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1976 PMID： 965210 DOI： 10.1007/BF02082213

Source DB: PubMed Journal: Int Urol Nephrol ISSN： 0301-1623 Impact factor: 2.370

Keyword Cloud
References

11 in total

1. A modified carbonate-phosphotungstate method for the determination of uric acid and comparison with the spectrophotometric uricase method.

Authors: R J HENRY; C SOBEL; J KIM
Journal: Am J Clin Pathol Date: 1957-08 Impact factor: 2.493

Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.

1. A modified carbonate-phosphotungstate method for the determination of uric acid and comparison with the spectrophotometric uricase method.

2. On the direct nesslerization of ammonia formed by urease treatment of blood, serum, and urine.

3. The determination of creatinine in plasma or serum, and in urine; a critical examination.

4. Reduced peritoneal clearances in scleroderma increased by intraperitoneal isoproterenol.

5. Altered peritoneal permeability in patients with systemic vasculitis.

6. Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection.

7. Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon.

8. Mechanisms for inefficient peritoneal dialysis in acute renal failure associated with heat stress and exercise.

9. Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid.

10. The ultrastructural basis of capillary permeability studied with peroxidase as a tracer.